Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXTEND study: extended prophylactic melagatran/ximelagatran vs enoxaparin after hip surgery
2004-002746-35Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- May 2005
- Modality
- Recombinant Proteins and Enzymes, Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in venous thromboembolism (VTE) comparing Melagatran/ximelagatran arm with Enoxaparin arm (2 arms). Started May 2005; status: completed.
02
Drugs
ximelagatranmelagatranenoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2004-002746-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002746-35.